{"transactions":[{"id":1463261,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-07-03T00:56:42.000Z","date":"2024-07-02","kind":"sale","planned":false,"acquired":false,"shares":95000,"price":8.68,"value":824600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.30 to $9.05, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":108793,"source":{"system":"sec-edgar","filing":"0000895345-24-000245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089534524000245/form4.xml","form_type":"4"}},{"id":1463260,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-07-03T00:56:42.000Z","date":"2024-07-01","kind":"sale","planned":false,"acquired":false,"shares":110731,"price":8.87,"value":982183.97,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.75 to $9.00, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":203793,"source":{"system":"sec-edgar","filing":"0000895345-24-000245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089534524000245/form4.xml","form_type":"4"}},{"id":1463259,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-07-03T00:56:42.000Z","date":"2024-06-28","kind":"sale","planned":false,"acquired":false,"shares":29000,"price":8.57,"value":248530.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.48 to $8.68, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":314524,"source":{"system":"sec-edgar","filing":"0000895345-24-000245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089534524000245/form4.xml","form_type":"4"}},{"id":1487045,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-06-08T01:14:32.000Z","date":"2024-06-07","kind":"sale","planned":false,"acquired":false,"shares":77000,"price":6.88,"value":529760.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.84 to $7.03, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":343524,"source":{"system":"sec-edgar","filing":"0000895345-24-000225","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089534524000225/form4.xml","form_type":"4"}},{"id":1487044,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-06-08T01:14:32.000Z","date":"2024-06-06","kind":"sale","planned":false,"acquired":false,"shares":63000,"price":7.24,"value":456120.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":420524,"source":{"system":"sec-edgar","filing":"0000895345-24-000225","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089534524000225/form4.xml","form_type":"4"}},{"id":1528528,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-05-04T01:34:33.000Z","date":"2024-05-03","kind":"sale","planned":false,"acquired":false,"shares":60000,"price":7.61,"value":456600.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.56 to $7.81, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":483524,"source":{"system":"sec-edgar","filing":"0000895345-24-000151","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089534524000151/form4.xml","form_type":"4"}},{"id":1528527,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-05-04T01:34:33.000Z","date":"2024-05-02","kind":"sale","planned":false,"acquired":false,"shares":75000,"price":7.56,"value":567000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.59, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":543524,"source":{"system":"sec-edgar","filing":"0000895345-24-000151","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089534524000151/form4.xml","form_type":"4"}},{"id":1528526,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-05-04T01:34:33.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":75000,"price":7.43,"value":557250.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.39 to $7.79, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":618524,"source":{"system":"sec-edgar","filing":"0000895345-24-000151","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089534524000151/form4.xml","form_type":"4"}},{"id":1654018,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See Remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See Remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See Remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See Remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See Remarks"}}],"security":"Warrant (right to purchase)","published_at":"2024-02-08T17:09:52.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":705280,"price":13.009,"value":9174987.52,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Warrants are exercisable immediately (subject to any applicable beneficial ownership limitation) and do not have an expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These Warrants are exercisable immediately (subject to any applicable beneficial ownership limitation) and do not have an expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. (\"Boxer Management\") is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Management. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":705280,"derivative":{"exercise_price":0.001,"underlying":"Common Stock","underlying_shares":705280},"source":{"system":"sec-edgar","filing":"0000895345-24-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000035/form4.xml","form_type":"4"}},{"id":1654017,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See Remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See Remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See Remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See Remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-08T17:09:52.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":63412,"price":13.01,"value":824990.12,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":85939,"source":{"system":"sec-edgar","filing":"0000895345-24-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000035/form4.xml","form_type":"4"}},{"id":1671322,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Warrant (right to purchase)","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1413475,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"By virtue of the Merger, each then unexpired and unexercised issued and outstanding warrant to purchase shares of Common Stock issued by or on behalf of the Company (each, a \"Company Warrant\") that was outstanding as of immediately prior to the Effective Time was converted into the right to receive, upon exercise of such Company Warrant, the same Merger Consideration as the holder would have been entitled to receive following the Effective Time if such holder had been, immediately prior to the Effective Time, the holder of the number of shares of Company common stock then issuable upon exercise in full of such Company Warrant without regard to any limitations on exercise contained therein."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"By virtue of the Merger, each then unexpired and unexercised issued and outstanding warrant to purchase shares of Common Stock issued by or on behalf of the Company (each, a \"Company Warrant\") that was outstanding as of immediately prior to the Effective Time was converted into the right to receive, upon exercise of such Company Warrant, the same Merger Consideration as the holder would have been entitled to receive following the Effective Time if such holder had been, immediately prior to the Effective Time, the holder of the number of shares of Company common stock then issuable upon exercise in full of such Company Warrant without regard to any limitations on exercise contained therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"These Company Warrants do not have an expiration date and are not exercisable to the extent that, following exercise, the holder of such Company Warrant and its affiliates would beneficially own more than 19.99% of the Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are owned directly by Braslyn Ltd., which is owned by a revocable trust established by Mr. Lewis for the benefit of members of his immediate family. Each reporting person other than Braslyn Ltd. and Mr. Lewis disclaims beneficial ownership of these securities."}],"balance_after":0,"derivative":{"exercise_price":0.001,"exercise_date":"2017-11-20","underlying":"Common Stock","underlying_shares":1413475},"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671321,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Warrant (right to purchase)","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3578036,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"By virtue of the Merger, each then unexpired and unexercised issued and outstanding warrant to purchase shares of Common Stock issued by or on behalf of the Company (each, a \"Company Warrant\") that was outstanding as of immediately prior to the Effective Time was converted into the right to receive, upon exercise of such Company Warrant, the same Merger Consideration as the holder would have been entitled to receive following the Effective Time if such holder had been, immediately prior to the Effective Time, the holder of the number of shares of Company common stock then issuable upon exercise in full of such Company Warrant without regard to any limitations on exercise contained therein."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"By virtue of the Merger, each then unexpired and unexercised issued and outstanding warrant to purchase shares of Common Stock issued by or on behalf of the Company (each, a \"Company Warrant\") that was outstanding as of immediately prior to the Effective Time was converted into the right to receive, upon exercise of such Company Warrant, the same Merger Consideration as the holder would have been entitled to receive following the Effective Time if such holder had been, immediately prior to the Effective Time, the holder of the number of shares of Company common stock then issuable upon exercise in full of such Company Warrant without regard to any limitations on exercise contained therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"These Company Warrants do not have an expiration date and are not exercisable to the extent that, following exercise, the holder of such Company Warrant and its affiliates would beneficially own more than 19.99% of the Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are owned directly by Braslyn Ltd., which is owned by a revocable trust established by Mr. Lewis for the benefit of members of his immediate family. Each reporting person other than Braslyn Ltd. and Mr. Lewis disclaims beneficial ownership of these securities."}],"balance_after":0,"derivative":{"exercise_price":0.001,"exercise_date":"2017-01-06","underlying":"Common Stock","underlying_shares":3578036},"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671320,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Warrant (right to purchase)","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":332809,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"By virtue of the Merger, each then unexpired and unexercised issued and outstanding warrant to purchase shares of Common Stock issued by or on behalf of the Company (each, a \"Company Warrant\") that was outstanding as of immediately prior to the Effective Time was converted into the right to receive, upon exercise of such Company Warrant, the same Merger Consideration as the holder would have been entitled to receive following the Effective Time if such holder had been, immediately prior to the Effective Time, the holder of the number of shares of Company common stock then issuable upon exercise in full of such Company Warrant without regard to any limitations on exercise contained therein."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"By virtue of the Merger, each then unexpired and unexercised issued and outstanding warrant to purchase shares of Common Stock issued by or on behalf of the Company (each, a \"Company Warrant\") that was outstanding as of immediately prior to the Effective Time was converted into the right to receive, upon exercise of such Company Warrant, the same Merger Consideration as the holder would have been entitled to receive following the Effective Time if such holder had been, immediately prior to the Effective Time, the holder of the number of shares of Company common stock then issuable upon exercise in full of such Company Warrant without regard to any limitations on exercise contained therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"These Company Warrants do not have an expiration date and are not exercisable to the extent that, following exercise, the holder of such Company Warrant and its affiliates would beneficially own more than 19.99% of the Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. (\"Boxer Management\") is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Management. Each of Messrs. Fuglesang, Dissanayake and Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":0.001,"exercise_date":"2017-11-20","underlying":"Common Stock","underlying_shares":332809},"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671319,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30518,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 23, 2024, Mirati Therapeutics, Inc. (the \"Company\") filed a Form 8-K with the SEC announcing the consummation of a transaction in which the Company became a wholly owned subsidiary of Bristol-Myers Squibb Company, as described in greater detail therein (the \"Merger\"). As described in that 8-K, upon the effective time (the \"Effective Time\") of the Merger each share of Company common stock, par value $0.001 per share, of the Company (\"Common Stock\") (with certain exceptions) was automatically converted into the right to receive (i) cash in an amount equal to $58.00 subject to applicable withholding tax and (ii) one contingent value right (a \"CVR\") representing the right to receive $12.00 in cash, without interest and subject to any applicable tax withholding upon achievement of a specified milestone is achieved (as further explained in the Form 8-K) (the consideration contemplated by (i) and (ii), together, the \"Merger Consideration\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These securities are owned directly by Mr. Fuglesang. Each reporting person other than Mr. Fuglesang disclaims beneficial ownership of these securities."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671318,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3135966,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 23, 2024, Mirati Therapeutics, Inc. (the \"Company\") filed a Form 8-K with the SEC announcing the consummation of a transaction in which the Company became a wholly owned subsidiary of Bristol-Myers Squibb Company, as described in greater detail therein (the \"Merger\"). As described in that 8-K, upon the effective time (the \"Effective Time\") of the Merger each share of Company common stock, par value $0.001 per share, of the Company (\"Common Stock\") (with certain exceptions) was automatically converted into the right to receive (i) cash in an amount equal to $58.00 subject to applicable withholding tax and (ii) one contingent value right (a \"CVR\") representing the right to receive $12.00 in cash, without interest and subject to any applicable tax withholding upon achievement of a specified milestone is achieved (as further explained in the Form 8-K) (the consideration contemplated by (i) and (ii), together, the \"Merger Consideration\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are owned directly by Braslyn Ltd., which is owned by a revocable trust established by Mr. Lewis for the benefit of members of his immediate family. Each reporting person other than Braslyn Ltd. and Mr. Lewis disclaims beneficial ownership of these securities."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671317,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":203754,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 23, 2024, Mirati Therapeutics, Inc. (the \"Company\") filed a Form 8-K with the SEC announcing the consummation of a transaction in which the Company became a wholly owned subsidiary of Bristol-Myers Squibb Company, as described in greater detail therein (the \"Merger\"). As described in that 8-K, upon the effective time (the \"Effective Time\") of the Merger each share of Company common stock, par value $0.001 per share, of the Company (\"Common Stock\") (with certain exceptions) was automatically converted into the right to receive (i) cash in an amount equal to $58.00 subject to applicable withholding tax and (ii) one contingent value right (a \"CVR\") representing the right to receive $12.00 in cash, without interest and subject to any applicable tax withholding upon achievement of a specified milestone is achieved (as further explained in the Form 8-K) (the consideration contemplated by (i) and (ii), together, the \"Merger Consideration\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are owned directly by Lockend Five, LLC, a limited liability company owned soley by Mr. Dissanayake.  Each reporting person other than Lockend Five, LLC and Mr. Dissanayake disclaims beneficial ownership of these securities."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671316,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3201440,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 23, 2024, Mirati Therapeutics, Inc. (the \"Company\") filed a Form 8-K with the SEC announcing the consummation of a transaction in which the Company became a wholly owned subsidiary of Bristol-Myers Squibb Company, as described in greater detail therein (the \"Merger\"). As described in that 8-K, upon the effective time (the \"Effective Time\") of the Merger each share of Company common stock, par value $0.001 per share, of the Company (\"Common Stock\") (with certain exceptions) was automatically converted into the right to receive (i) cash in an amount equal to $58.00 subject to applicable withholding tax and (ii) one contingent value right (a \"CVR\") representing the right to receive $12.00 in cash, without interest and subject to any applicable tax withholding upon achievement of a specified milestone is achieved (as further explained in the Form 8-K) (the consideration contemplated by (i) and (ii), together, the \"Merger Consideration\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. (\"Boxer Management\") is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Management. Each of Messrs. Fuglesang, Dissanayake and Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671315,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":287866,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 23, 2024, Mirati Therapeutics, Inc. (the \"Company\") filed a Form 8-K with the SEC announcing the consummation of a transaction in which the Company became a wholly owned subsidiary of Bristol-Myers Squibb Company, as described in greater detail therein (the \"Merger\"). As described in that 8-K, upon the effective time (the \"Effective Time\") of the Merger each share of Company common stock, par value $0.001 per share, of the Company (\"Common Stock\") (with certain exceptions) was automatically converted into the right to receive (i) cash in an amount equal to $58.00 subject to applicable withholding tax and (ii) one contingent value right (a \"CVR\") representing the right to receive $12.00 in cash, without interest and subject to any applicable tax withholding upon achievement of a specified milestone is achieved (as further explained in the Form 8-K) (the consideration contemplated by (i) and (ii), together, the \"Merger Consideration\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1759272,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":5,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-10-17T19:41:18.000Z","date":"2023-10-16","kind":"purchase","planned":false,"acquired":true,"shares":500000,"price":6.84,"value":3420000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.54 to $7.01, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":8198642,"source":{"system":"sec-edgar","filing":"0000895345-23-000589","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000589/form4.xml","form_type":"4/A","original_submission_date":"2023-10-17"}},{"id":1759271,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":5,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-10-17T19:41:18.000Z","date":"2023-10-13","kind":"purchase","planned":false,"acquired":true,"shares":750000,"price":7.07,"value":5302500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.95 to $7.10, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":7698642,"source":{"system":"sec-edgar","filing":"0000895345-23-000589","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000589/form4.xml","form_type":"4/A","original_submission_date":"2023-10-17"}},{"id":1759270,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":5,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-10-17T18:04:34.000Z","date":"2023-10-16","kind":"purchase","planned":true,"acquired":true,"shares":500000,"price":6.84,"value":3420000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.54 to $7.01, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":8198642,"source":{"system":"sec-edgar","filing":"0000895345-23-000588","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000588/form4.xml","form_type":"4"}},{"id":1759269,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":5,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-10-17T18:04:34.000Z","date":"2023-10-13","kind":"purchase","planned":true,"acquired":true,"shares":750000,"price":7.07,"value":5302500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.95 to $7.10, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":7698642,"source":{"system":"sec-edgar","filing":"0000895345-23-000588","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000588/form4.xml","form_type":"4"}},{"id":1762000,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-10-11T21:22:57.000Z","date":"2023-10-09","kind":"sale","planned":false,"acquired":false,"shares":175000,"price":9.97,"value":1744750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.6943 to $10.1829, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":6948642,"source":{"system":"sec-edgar","filing":"0000895345-23-000574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000574/form4.xml","form_type":"4"}},{"id":1761999,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-10-11T21:22:57.000Z","date":"2023-10-09","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":9.91,"value":495500.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ 9.6500 to $9.9800, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":693524,"source":{"system":"sec-edgar","filing":"0000895345-23-000574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000574/form4.xml","form_type":"4"}},{"id":1761998,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":true,"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":true,"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":true,"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"other":true,"other_text":"See remarks"}}],"security":"Prefunded Warrant","published_at":"2023-10-11T19:22:22.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":2340579,"price":5.1499,"value":12053747.7921,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The prefunded warrants have an exercise price of $0.001 per share of Common Stock and are immediately exercisable and remain exercisable until exercised in full, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The prefunded warrants have an exercise price of $0.001 per share of Common Stock and are immediately exercisable and remain exercisable until exercised in full, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The prefunded warrants have an exercise price of $0.001 per share of Common Stock and are immediately exercisable and remain exercisable until exercised in full, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":2340579,"derivative":{"underlying":"Common Stock","underlying_shares":2340579},"source":{"system":"sec-edgar","filing":"0000895345-23-000573","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000573/form4.xml","form_type":"4/A","original_submission_date":"2023-08-15"}},{"id":1761997,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":true,"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":true,"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":true,"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-10-11T19:22:22.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":475000,"price":5.15,"value":2446250.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":743542,"source":{"system":"sec-edgar","filing":"0000895345-23-000573","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000573/form4.xml","form_type":"4/A","original_submission_date":"2023-08-15"}},{"id":1807689,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-08-15T21:39:22.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":1201440,"price":27.8,"value":33400032.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. (\"Boxer Management\") is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Management. Each of Messrs. Fuglesang, Dissanayake and Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":3201440,"source":{"system":"sec-edgar","filing":"0000895345-23-000500","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000500/form4.xml","form_type":"4"}},{"id":1807688,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-08-15T21:39:22.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":57533,"price":27.8,"value":1599417.4,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":287866,"source":{"system":"sec-edgar","filing":"0000895345-23-000500","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000500/form4.xml","form_type":"4"}},{"id":1807687,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-08-15T21:38:44.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":1201440,"price":27.8,"value":33400032.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. (\"Boxer Management\") is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Management. Each of Messrs. Fuglesang, Dissanayake and Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":3201440,"source":{"system":"sec-edgar","filing":"0000895345-23-000499","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000499/form4.xml","form_type":"4"}},{"id":1807686,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-08-15T21:38:44.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":57533,"price":27.8,"value":1599417.4,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":287866,"source":{"system":"sec-edgar","filing":"0000895345-23-000499","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000499/form4.xml","form_type":"4"}},{"id":1807685,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Prefunded Warrant","published_at":"2023-08-15T21:34:39.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":2340579,"price":5.1499,"value":12053747.7921,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The prefunded warrants have an exercise price of $0.001 per share of Common Stock and are immediately exercisable and remain exercisable until exercised in full, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The prefunded warrants have an exercise price of $0.001 per share of Common Stock and are immediately exercisable and remain exercisable until exercised in full, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The prefunded warrants have an exercise price of $0.001 per share of Common Stock and are immediately exercisable and remain exercisable until exercised in full, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":2340597,"derivative":{"underlying":"Common Stock","underlying_shares":2340579},"source":{"system":"sec-edgar","filing":"0000895345-23-000498","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000498/form4.xml","form_type":"4"}},{"id":1807684,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-08-15T21:34:39.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":475000,"price":5.15,"value":2446250.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":743542,"source":{"system":"sec-edgar","filing":"0000895345-23-000498","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000498/form4.xml","form_type":"4"}},{"id":2020225,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"ten_percent_owner":true}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-02-14T02:39:49.000Z","date":"2023-02-10","kind":"sale","acquired":false,"shares":65568,"price":13.4,"value":878611.2,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held directly by MVA Investors, LLC (\"MVA Investors\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) MVA Investors, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) Aaron I. Davis, (v) Joseph C. Lewis and (vi) Siddarth Subramony  (collectively, the \"Boxer Group\"), and indirectly by Mr. Davis who is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":22527,"source":{"system":"sec-edgar","filing":"0000895345-23-000107","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000089534523000107/form4.xml","form_type":"4"}},{"id":2020224,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"ten_percent_owner":true}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-02-14T02:39:49.000Z","date":"2023-02-09","kind":"sale","acquired":false,"shares":200000,"price":13.1,"value":2620000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held directly by MVA Investors, LLC (\"MVA Investors\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) MVA Investors, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) Aaron I. Davis, (v) Joseph C. Lewis and (vi) Siddarth Subramony  (collectively, the \"Boxer Group\"), and indirectly by Mr. Davis who is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":88095,"source":{"system":"sec-edgar","filing":"0000895345-23-000107","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000089534523000107/form4.xml","form_type":"4"}},{"id":2137885,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-10-13T21:30:12.000Z","date":"2022-10-13","kind":"purchase","acquired":true,"shares":70000,"price":4.6461,"value":325227.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":7123642,"source":{"system":"sec-edgar","filing":"0000899243-22-033595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322033595/doc4.xml","form_type":"4"}},{"id":2137884,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-10-13T21:30:12.000Z","date":"2022-10-12","kind":"purchase","acquired":true,"shares":50000,"price":4.4328,"value":221640.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, LLC (\"Boxer Capital\"), (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Joseph C. Lewis, (iv) BCTG Holdings, LLC, (v) MVA Investors and (vi) Aaron I. Davis (collectively, the \"Boxer Group\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":268524,"source":{"system":"sec-edgar","filing":"0000899243-22-033595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322033595/doc4.xml","form_type":"4"}},{"id":2137883,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-10-13T21:30:12.000Z","date":"2022-10-11","kind":"purchase","acquired":true,"shares":117000,"price":4.2539,"value":497706.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $4.0500 to $4.2631."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, LLC (\"Boxer Capital\"), (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Joseph C. Lewis, (iv) BCTG Holdings, LLC, (v) MVA Investors and (vi) Aaron I. Davis (collectively, the \"Boxer Group\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":218524,"source":{"system":"sec-edgar","filing":"0000899243-22-033595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322033595/doc4.xml","form_type":"4"}},{"id":2445374,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":2517,"price":45.4777,"value":114467.3709,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein. Following the completion of the transactions reported in this Form 4, MVA Investors no longer holds any securities of the issuer and, therefore, as of January 4, 2022, is no longer a member of the Boxer Group"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445373,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":11199,"price":44.4416,"value":497701.4784,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein. Following the completion of the transactions reported in this Form 4, MVA Investors no longer holds any securities of the issuer and, therefore, as of January 4, 2022, is no longer a member of the Boxer Group"}],"balance_after":2517,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445372,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":3138,"price":43.3596,"value":136062.4248,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $42.6291 to $43.4221."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein. Following the completion of the transactions reported in this Form 4, MVA Investors no longer holds any securities of the issuer and, therefore, as of January 4, 2022, is no longer a member of the Boxer Group"}],"balance_after":13716,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445371,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":29623,"price":41.842,"value":1239485.566,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $41.4811 to $42.1440."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein. Following the completion of the transactions reported in this Form 4, MVA Investors no longer holds any securities of the issuer and, therefore, as of January 4, 2022, is no longer a member of the Boxer Group"}],"balance_after":16854,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445370,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":7483,"price":45.4777,"value":340309.6291,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) MVA Investors, LLC (\"MVA Investors\"), (iv) Aaron I. Davis, and (v) Joseph C. Lewis (collectively, the \"Boxer Group\").  These securities are owned indirectly by Boxer Management and Joseph C. Lewis, by virtue of their ownership of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3717259,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445369,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":33297,"price":44.4416,"value":1479771.9552,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) MVA Investors, LLC (\"MVA Investors\"), (iv) Aaron I. Davis, and (v) Joseph C. Lewis (collectively, the \"Boxer Group\").  These securities are owned indirectly by Boxer Management and Joseph C. Lewis, by virtue of their ownership of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3724742,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445368,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":9366,"price":43.36,"value":406109.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $42.6291 to $43.4221."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) MVA Investors, LLC (\"MVA Investors\"), (iv) Aaron I. Davis, and (v) Joseph C. Lewis (collectively, the \"Boxer Group\").  These securities are owned indirectly by Boxer Management and Joseph C. Lewis, by virtue of their ownership of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3758039,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445367,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":88054,"price":41.842,"value":3684355.468,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $41.4811 to $42.1440."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) MVA Investors, LLC (\"MVA Investors\"), (iv) Aaron I. Davis, and (v) Joseph C. Lewis (collectively, the \"Boxer Group\").  These securities are owned indirectly by Boxer Management and Joseph C. Lewis, by virtue of their ownership of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3767405,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445366,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":731,"price":50.6338,"value":37013.3078,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein. Following the completion of the transactions reported in this Form 4, MVA Investors no longer holds any securities of the issuer and, therefore, as of January 4, 2022, is no longer a member of the Boxer Group"}],"balance_after":46477,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445365,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":1682,"price":49.3749,"value":83048.5818,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $49.2035 to $50.1716."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein. Following the completion of the transactions reported in this Form 4, MVA Investors no longer holds any securities of the issuer and, therefore, as of January 4, 2022, is no longer a member of the Boxer Group"}],"balance_after":47208,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445364,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":23353,"price":47.6275,"value":1112245.0075,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $47.4904 to $47.8617."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein. Following the completion of the transactions reported in this Form 4, MVA Investors no longer holds any securities of the issuer and, therefore, as of January 4, 2022, is no longer a member of the Boxer Group"}],"balance_after":48890,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445363,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":17173,"price":50.6338,"value":869534.2474,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) MVA Investors, LLC (\"MVA Investors\"), (iv) Aaron I. Davis, and (v) Joseph C. Lewis (collectively, the \"Boxer Group\").  These securities are owned indirectly by Boxer Management and Joseph C. Lewis, by virtue of their ownership of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3855459,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445362,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":39481,"price":49.3745,"value":1949354.6345,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $49.2035 to $50.1716."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) MVA Investors, LLC (\"MVA Investors\"), (iv) Aaron I. Davis, and (v) Joseph C. Lewis (collectively, the \"Boxer Group\").  These securities are owned indirectly by Boxer Management and Joseph C. Lewis, by virtue of their ownership of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3872632,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445361,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":432903,"price":47.6462,"value":20626182.9186,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $47.4904 to $47.8617."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) MVA Investors, LLC (\"MVA Investors\"), (iv) Aaron I. Davis, and (v) Joseph C. Lewis (collectively, the \"Boxer Group\").  These securities are owned indirectly by Boxer Management and Joseph C. Lewis, by virtue of their ownership of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3912113,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2566583,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-09-17T16:38:38.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":15401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into shares of the Issuer's common stock at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into shares of the Issuer's common stock at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into shares of the Issuer's common stock at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are held directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, and indirectly by Mr. Davis who is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":40002},"source":{"system":"sec-edgar","filing":"0000899243-21-036419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321036419/doc4.xml","form_type":"4"}},{"id":2566582,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-09-17T16:38:38.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":713629,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into shares of the Issuer's common stock at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into shares of the Issuer's common stock at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into shares of the Issuer's common stock at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Joseph C. Lewis, (iv) MVA Investors, LLC and (v) Aaron I. Davis (collectively, the \"Boxer Group\"), and indirectly by Boxer Management and Joseph C. Lewis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1853579},"source":{"system":"sec-edgar","filing":"0000899243-21-036419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321036419/doc4.xml","form_type":"4"}},{"id":2566581,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-09-17T16:38:38.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":95516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into shares of the Issuer's common stock at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into shares of the Issuer's common stock at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into shares of the Issuer's common stock at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are held directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, and indirectly by Mr. Davis who is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":248093},"source":{"system":"sec-edgar","filing":"0000899243-21-036419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321036419/doc4.xml","form_type":"4"}},{"id":2566580,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-09-17T16:38:38.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":1480242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into shares of the Issuer's common stock at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into shares of the Issuer's common stock at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into shares of the Issuer's common stock at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Joseph C. Lewis, (iv) MVA Investors, LLC and (v) Aaron I. Davis (collectively, the \"Boxer Group\"), and indirectly by Boxer Management and Joseph C. Lewis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3844780},"source":{"system":"sec-edgar","filing":"0000899243-21-036419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321036419/doc4.xml","form_type":"4"}},{"id":2566579,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-09-17T16:38:38.000Z","date":"2021-09-17","kind":"exercise","acquired":true,"shares":288095,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into shares of the Issuer's common stock at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are held directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, and indirectly by Mr. Davis who is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":288095,"source":{"system":"sec-edgar","filing":"0000899243-21-036419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321036419/doc4.xml","form_type":"4"}},{"id":2566578,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-09-17T16:38:38.000Z","date":"2021-09-17","kind":"purchase","acquired":true,"shares":625000,"price":16,"value":10000000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Joseph C. Lewis, (iv) MVA Investors, LLC and (v) Aaron I. Davis (collectively, the \"Boxer Group\"), and indirectly by Boxer Management and Joseph C. Lewis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":6323359,"source":{"system":"sec-edgar","filing":"0000899243-21-036419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321036419/doc4.xml","form_type":"4"}},{"id":2566577,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-09-17T16:38:38.000Z","date":"2021-09-17","kind":"exercise","acquired":true,"shares":5698359,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into shares of the Issuer's common stock at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock.  The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Joseph C. Lewis, (iv) MVA Investors, LLC and (v) Aaron I. Davis (collectively, the \"Boxer Group\"), and indirectly by Boxer Management and Joseph C. Lewis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":5698359,"source":{"system":"sec-edgar","filing":"0000899243-21-036419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321036419/doc4.xml","form_type":"4"}},{"id":2738578,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":2,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Non-Voting Common Stock","published_at":"2021-04-27T17:09:25.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":79726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Preferred Stock was convertible into Common Stock on a one-for-1.0799 basis at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date. Pursuant to an Exchange Agreement, dated April 17, 2021, the shares of Series B Preferred Stock reported herein were exchanged for shares of Non-Voting Common Stock on a one-for-1.0799 basis immediately prior to the closing of the Issuer's initial public offering without payment or additional consideration. Each share of Non-Voting Common Stock is convertible into one share of Common Stock at any time at the option of the holder without payment or additional consideration, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Preferred Stock was convertible into Common Stock on a one-for-1.0799 basis at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date. Pursuant to an Exchange Agreement, dated April 17, 2021, the shares of Series B Preferred Stock reported herein were exchanged for shares of Non-Voting Common Stock on a one-for-1.0799 basis immediately prior to the closing of the Issuer's initial public offering without payment or additional consideration. Each share of Non-Voting Common Stock is convertible into one share of Common Stock at any time at the option of the holder without payment or additional consideration, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock was convertible into Common Stock on a one-for-1.0799 basis at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date. Pursuant to an Exchange Agreement, dated April 17, 2021, the shares of Series B Preferred Stock reported herein were exchanged for shares of Non-Voting Common Stock on a one-for-1.0799 basis immediately prior to the closing of the Issuer's initial public offering without payment or additional consideration. Each share of Non-Voting Common Stock is convertible into one share of Common Stock at any time at the option of the holder without payment or additional consideration, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, and indirectly by Mr. Davis who is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":79726,"derivative":{"underlying":"Common Stock","underlying_shares":79726},"source":{"system":"sec-edgar","filing":"0000899243-21-017115","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924321017115/doc4.xml","form_type":"4"}},{"id":2738577,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":2,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Non-Voting Common Stock","published_at":"2021-04-27T17:09:25.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":3022489,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Preferred Stock was convertible into Common Stock on a one-for-1.0799 basis at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date. Pursuant to an Exchange Agreement, dated April 17, 2021, the shares of Series B Preferred Stock reported herein were exchanged for shares of Non-Voting Common Stock on a one-for-1.0799 basis immediately prior to the closing of the Issuer's initial public offering without payment or additional consideration. Each share of Non-Voting Common Stock is convertible into one share of Common Stock at any time at the option of the holder without payment or additional consideration, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Preferred Stock was convertible into Common Stock on a one-for-1.0799 basis at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date. Pursuant to an Exchange Agreement, dated April 17, 2021, the shares of Series B Preferred Stock reported herein were exchanged for shares of Non-Voting Common Stock on a one-for-1.0799 basis immediately prior to the closing of the Issuer's initial public offering without payment or additional consideration. Each share of Non-Voting Common Stock is convertible into one share of Common Stock at any time at the option of the holder without payment or additional consideration, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock was convertible into Common Stock on a one-for-1.0799 basis at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date. Pursuant to an Exchange Agreement, dated April 17, 2021, the shares of Series B Preferred Stock reported herein were exchanged for shares of Non-Voting Common Stock on a one-for-1.0799 basis immediately prior to the closing of the Issuer's initial public offering without payment or additional consideration. Each share of Non-Voting Common Stock is convertible into one share of Common Stock at any time at the option of the holder without payment or additional consideration, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Aaron I. Davis, (iv) MVA Investors, LLC (\"MVA Investors\"), and (v) Joe Lewis (collectively, the \"Boxer Group\"), and indirectly by Boxer Management, Mr. Lewis and Mr. Davis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3022489,"derivative":{"underlying":"Common Stock","underlying_shares":3022489},"source":{"system":"sec-edgar","filing":"0000899243-21-017115","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924321017115/doc4.xml","form_type":"4"}},{"id":2738576,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":2,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-04-27T17:09:25.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":86097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Preferred Stock was convertible into Common Stock on a one-for-1.0799 basis at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date. Pursuant to an Exchange Agreement, dated April 17, 2021, the shares of Series B Preferred Stock reported herein were exchanged for shares of Non-Voting Common Stock on a one-for-1.0799 basis immediately prior to the closing of the Issuer's initial public offering without payment or additional consideration. Each share of Non-Voting Common Stock is convertible into one share of Common Stock at any time at the option of the holder without payment or additional consideration, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Preferred Stock was convertible into Common Stock on a one-for-1.0799 basis at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date. Pursuant to an Exchange Agreement, dated April 17, 2021, the shares of Series B Preferred Stock reported herein were exchanged for shares of Non-Voting Common Stock on a one-for-1.0799 basis immediately prior to the closing of the Issuer's initial public offering without payment or additional consideration. Each share of Non-Voting Common Stock is convertible into one share of Common Stock at any time at the option of the holder without payment or additional consideration, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock was convertible into Common Stock on a one-for-1.0799 basis at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date. Pursuant to an Exchange Agreement, dated April 17, 2021, the shares of Series B Preferred Stock reported herein were exchanged for shares of Non-Voting Common Stock on a one-for-1.0799 basis immediately prior to the closing of the Issuer's initial public offering without payment or additional consideration. Each share of Non-Voting Common Stock is convertible into one share of Common Stock at any time at the option of the holder without payment or additional consideration, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, and indirectly by Mr. Davis who is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Non-Voting Common Stock","underlying_shares":79726},"source":{"system":"sec-edgar","filing":"0000899243-21-017115","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924321017115/doc4.xml","form_type":"4"}},{"id":2738575,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":2,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-04-27T17:09:25.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":3263986,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Preferred Stock was convertible into Common Stock on a one-for-1.0799 basis at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date. Pursuant to an Exchange Agreement, dated April 17, 2021, the shares of Series B Preferred Stock reported herein were exchanged for shares of Non-Voting Common Stock on a one-for-1.0799 basis immediately prior to the closing of the Issuer's initial public offering without payment or additional consideration. Each share of Non-Voting Common Stock is convertible into one share of Common Stock at any time at the option of the holder without payment or additional consideration, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Preferred Stock was convertible into Common Stock on a one-for-1.0799 basis at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date. Pursuant to an Exchange Agreement, dated April 17, 2021, the shares of Series B Preferred Stock reported herein were exchanged for shares of Non-Voting Common Stock on a one-for-1.0799 basis immediately prior to the closing of the Issuer's initial public offering without payment or additional consideration. Each share of Non-Voting Common Stock is convertible into one share of Common Stock at any time at the option of the holder without payment or additional consideration, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock was convertible into Common Stock on a one-for-1.0799 basis at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date. Pursuant to an Exchange Agreement, dated April 17, 2021, the shares of Series B Preferred Stock reported herein were exchanged for shares of Non-Voting Common Stock on a one-for-1.0799 basis immediately prior to the closing of the Issuer's initial public offering without payment or additional consideration. Each share of Non-Voting Common Stock is convertible into one share of Common Stock at any time at the option of the holder without payment or additional consideration, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Aaron I. Davis, (iv) MVA Investors, LLC (\"MVA Investors\"), and (v) Joe Lewis (collectively, the \"Boxer Group\"), and indirectly by Boxer Management, Mr. Lewis and Mr. Davis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Non-Voting Common Stock","underlying_shares":3022489},"source":{"system":"sec-edgar","filing":"0000899243-21-017115","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924321017115/doc4.xml","form_type":"4"}},{"id":2738574,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":2,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-27T17:09:25.000Z","date":"2021-04-27","kind":"purchase","acquired":true,"shares":1025000,"price":17,"value":17425000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Aaron I. Davis, (iv) MVA Investors, LLC (\"MVA Investors\"), and (v) Joe Lewis (collectively, the \"Boxer Group\"), and indirectly by Boxer Management, Mr. Lewis and Mr. Davis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":1175000,"source":{"system":"sec-edgar","filing":"0000899243-21-017115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924321017115/doc4.xml","form_type":"4"}},{"id":2738573,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":2,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-27T17:09:25.000Z","date":"2021-04-23","kind":"purchase","acquired":true,"shares":125000,"price":16.27,"value":2033750.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Aaron I. Davis, (iv) MVA Investors, LLC (\"MVA Investors\"), and (v) Joe Lewis (collectively, the \"Boxer Group\"), and indirectly by Boxer Management, Mr. Lewis and Mr. Davis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0000899243-21-017115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924321017115/doc4.xml","form_type":"4"}},{"id":2738572,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":2,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-27T17:09:25.000Z","date":"2021-04-23","kind":"purchase","acquired":true,"shares":25000,"price":15.58,"value":389500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Aaron I. Davis, (iv) MVA Investors, LLC (\"MVA Investors\"), and (v) Joe Lewis (collectively, the \"Boxer Group\"), and indirectly by Boxer Management, Mr. Lewis and Mr. Davis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0000899243-21-017115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924321017115/doc4.xml","form_type":"4"}},{"id":2801110,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":7,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":8,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2021-03-09T21:48:57.000Z","date":"2021-03-05","kind":"exercise","acquired":false,"shares":468639,"price":12.999,"value":6091838.361,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd. (\"Braslyn\"), (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group), and indirectly by Braslyn, Boxer Management and Messrs. Lewis, Fuglesang, Lieberburg, Dissanayake and Davis, by virtue of their ownership in Boxer Capital."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"(Continued from Footnote 2) Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":332809,"derivative":{"exercise_price":0.001,"exercise_date":"2017-11-20","underlying":"Common Stock","underlying_shares":468639},"source":{"system":"sec-edgar","filing":"0000899243-21-010812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321010812/doc4.xml","form_type":"4"}},{"id":2801109,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":7,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":8,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2021-03-09T21:48:57.000Z","date":"2021-03-05","kind":"exercise","acquired":false,"shares":128805,"price":5.599,"value":721179.195,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd. (\"Braslyn\"), (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group), and indirectly by Braslyn, Boxer Management and Messrs. Lewis, Fuglesang, Lieberburg, Dissanayake and Davis, by virtue of their ownership in Boxer Capital."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"(Continued from Footnote 2) Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.001,"exercise_date":"2017-01-06","underlying":"Common Stock","underlying_shares":128805},"source":{"system":"sec-edgar","filing":"0000899243-21-010812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321010812/doc4.xml","form_type":"4"}},{"id":2801108,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":7,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":8,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2021-03-09T21:48:57.000Z","date":"2021-03-05","kind":"exercise","acquired":false,"shares":13996,"price":5.599,"value":78363.604,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.001,"exercise_date":"2017-01-06","underlying":"Common Stock","underlying_shares":13996},"source":{"system":"sec-edgar","filing":"0000899243-21-010812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321010812/doc4.xml","form_type":"4"}},{"id":2801107,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":7,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":8,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-09T21:48:57.000Z","date":"2021-03-05","kind":"sale","acquired":false,"shares":363000,"price":181.15,"value":65757450.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd. (\"Braslyn\"), (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group), and indirectly by Braslyn, Boxer Management and Messrs. Lewis, Fuglesang, Lieberburg, Dissanayake and Davis, by virtue of their ownership in Boxer Capital."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"(Continued from Footnote 2) Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":2000000,"source":{"system":"sec-edgar","filing":"0000899243-21-010812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321010812/doc4.xml","form_type":"4"}},{"id":2801106,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":7,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":8,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-09T21:48:57.000Z","date":"2021-03-05","kind":"sale","acquired":false,"shares":4,"price":181,"value":724.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd. (\"Braslyn\"), (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group), and indirectly by Braslyn, Boxer Management and Messrs. Lewis, Fuglesang, Lieberburg, Dissanayake and Davis, by virtue of their ownership in Boxer Capital."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"(Continued from Footnote 2) Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":2363000,"source":{"system":"sec-edgar","filing":"0000899243-21-010812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321010812/doc4.xml","form_type":"4"}},{"id":2801105,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":7,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":8,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-09T21:48:57.000Z","date":"2021-03-05","kind":"exercise","acquired":true,"shares":597444,"price":0.001,"value":597.444,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd. (\"Braslyn\"), (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group), and indirectly by Braslyn, Boxer Management and Messrs. Lewis, Fuglesang, Lieberburg, Dissanayake and Davis, by virtue of their ownership in Boxer Capital."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"(Continued from Footnote 2) Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":2363004,"source":{"system":"sec-edgar","filing":"0000899243-21-010812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321010812/doc4.xml","form_type":"4"}},{"id":2801104,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":7,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":8,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-09T21:48:57.000Z","date":"2021-03-05","kind":"sale","acquired":false,"shares":37000,"price":181.15,"value":6702550.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":230333,"source":{"system":"sec-edgar","filing":"0000899243-21-010812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321010812/doc4.xml","form_type":"4"}},{"id":2801103,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":7,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":8,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-09T21:48:57.000Z","date":"2021-03-05","kind":"sale","acquired":false,"shares":1,"price":181,"value":181.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":267333,"source":{"system":"sec-edgar","filing":"0000899243-21-010812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321010812/doc4.xml","form_type":"4"}},{"id":2801102,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":7,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":8,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-09T21:48:57.000Z","date":"2021-03-05","kind":"exercise","acquired":true,"shares":13996,"price":0.001,"value":13.996,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":267334,"source":{"system":"sec-edgar","filing":"0000899243-21-010812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321010812/doc4.xml","form_type":"4"}},{"id":2997692,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":7,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":8,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2020-10-30T21:54:12.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"shares":37051,"price":5.599,"value":207448.549,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by MVA Investors which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":13996,"derivative":{"exercise_price":0.001,"exercise_date":"2017-01-06","underlying":"Common Stock","underlying_shares":37051},"source":{"system":"sec-edgar","filing":"0000899243-20-030060","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030060/doc4.xml","form_type":"4"}},{"id":2997691,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":7,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":8,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2020-10-30T21:54:12.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"shares":362952,"price":5.599,"value":2032168.248,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd. (\"Braslyn\"), (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group), and indirectly by Braslyn, Boxer Management and Messrs. Lewis, Fuglesang, Lieberburg, Dissanayake and Davis, by virtue of their ownership in Boxer Capital.. Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"(Continued from Footnote 1) Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":128805,"derivative":{"exercise_price":0.001,"exercise_date":"2017-01-06","underlying":"Common Stock","underlying_shares":362952},"source":{"system":"sec-edgar","filing":"0000899243-20-030060","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030060/doc4.xml","form_type":"4"}},{"id":2997690,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":7,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":8,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:54:12.000Z","date":"2020-10-30","kind":"tax_withholding","acquired":false,"shares":2,"price":219.97,"value":439.94,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd. (\"Braslyn\"), (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group), and indirectly by Braslyn, Boxer Management and Messrs. Lewis, Fuglesang, Lieberburg, Dissanayake and Davis, by virtue of their ownership in Boxer Capital.. Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"(Continued from Footnote 1) Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":1765560,"source":{"system":"sec-edgar","filing":"0000899243-20-030060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030060/doc4.xml","form_type":"4"}},{"id":2997689,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":7,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":8,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:54:12.000Z","date":"2020-10-30","kind":"exercise","acquired":true,"shares":362952,"price":0.001,"value":362.952,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd. (\"Braslyn\"), (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group), and indirectly by Braslyn, Boxer Management and Messrs. Lewis, Fuglesang, Lieberburg, Dissanayake and Davis, by virtue of their ownership in Boxer Capital.. Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"(Continued from Footnote 1) Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":1765562,"source":{"system":"sec-edgar","filing":"0000899243-20-030060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030060/doc4.xml","form_type":"4"}},{"id":2997688,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":7,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":8,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:54:12.000Z","date":"2020-10-30","kind":"sale","acquired":false,"shares":362950,"price":202,"value":73315900.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd. (\"Braslyn\"), (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group), and indirectly by Braslyn, Boxer Management and Messrs. Lewis, Fuglesang, Lieberburg, Dissanayake and Davis, by virtue of their ownership in Boxer Capital.. Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"(Continued from Footnote 1) Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":1404610,"source":{"system":"sec-edgar","filing":"0000899243-20-030060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030060/doc4.xml","form_type":"4"}},{"id":2997687,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":7,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":8,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:54:12.000Z","date":"2020-10-30","kind":"tax_withholding","acquired":false,"shares":1,"price":219.97,"value":219.97,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by MVA Investors which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":253338,"source":{"system":"sec-edgar","filing":"0000899243-20-030060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030060/doc4.xml","form_type":"4"}},{"id":2997686,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":7,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":8,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:54:12.000Z","date":"2020-10-30","kind":"exercise","acquired":true,"shares":37051,"price":0.001,"value":37.051,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by MVA Investors which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":253339,"source":{"system":"sec-edgar","filing":"0000899243-20-030060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030060/doc4.xml","form_type":"4"}},{"id":2997685,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":7,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":8,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:54:12.000Z","date":"2020-10-30","kind":"sale","acquired":false,"shares":37050,"price":202,"value":7484100.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by MVA Investors which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":216288,"source":{"system":"sec-edgar","filing":"0000899243-20-030060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030060/doc4.xml","form_type":"4"}},{"id":3021088,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series D Preferred Stock","published_at":"2020-09-29T16:40:53.000Z","date":"2020-09-29","kind":"exercise","acquired":false,"shares":28129,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares of each of the Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of each of the Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of each of the Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":28129},"source":{"system":"sec-edgar","filing":"0001209191-20-052341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000120919120052341/doc4.xml","form_type":"4"}},{"id":3021087,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series D Preferred Stock","published_at":"2020-09-29T16:40:53.000Z","date":"2020-09-29","kind":"exercise","acquired":false,"shares":732137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares of each of the Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of each of the Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of each of the Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares are held of record by Boxer Capital, LLC (\"Boxer Capital\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) MVA Investors, LLC (\"MVA Investors\") (iv) Aaron I. Davis, and (v) Joe Lewis (collectively, the \"Boxer Group\"). Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it does not have a pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":732137},"source":{"system":"sec-edgar","filing":"0001209191-20-052341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000120919120052341/doc4.xml","form_type":"4"}},{"id":3021086,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series C Preferred Stock","published_at":"2020-09-29T16:40:53.000Z","date":"2020-09-29","kind":"exercise","acquired":false,"shares":32708,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares of each of the Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of each of the Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of each of the Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":32708},"source":{"system":"sec-edgar","filing":"0001209191-20-052341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000120919120052341/doc4.xml","form_type":"4"}},{"id":3021085,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series C Preferred Stock","published_at":"2020-09-29T16:40:53.000Z","date":"2020-09-29","kind":"exercise","acquired":false,"shares":586099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares of each of the Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of each of the Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of each of the Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares are held of record by Boxer Capital, LLC (\"Boxer Capital\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) MVA Investors, LLC (\"MVA Investors\") (iv) Aaron I. Davis, and (v) Joe Lewis (collectively, the \"Boxer Group\"). Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it does not have a pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":586099},"source":{"system":"sec-edgar","filing":"0001209191-20-052341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000120919120052341/doc4.xml","form_type":"4"}},{"id":3021084,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-09-29T16:40:53.000Z","date":"2020-09-29","kind":"exercise","acquired":true,"shares":28129,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of each of the Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":60837,"source":{"system":"sec-edgar","filing":"0001209191-20-052341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000120919120052341/doc4.xml","form_type":"4"}},{"id":3021083,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-09-29T16:40:53.000Z","date":"2020-09-29","kind":"exercise","acquired":true,"shares":32708,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of each of the Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":32708,"source":{"system":"sec-edgar","filing":"0001209191-20-052341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000120919120052341/doc4.xml","form_type":"4"}},{"id":3021082,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-09-29T16:40:53.000Z","date":"2020-09-29","kind":"exercise","acquired":true,"shares":732137,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of each of the Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares are held of record by Boxer Capital, LLC (\"Boxer Capital\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) MVA Investors, LLC (\"MVA Investors\") (iv) Aaron I. Davis, and (v) Joe Lewis (collectively, the \"Boxer Group\"). Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it does not have a pecuniary interest therein."}],"balance_after":2268236,"source":{"system":"sec-edgar","filing":"0001209191-20-052341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000120919120052341/doc4.xml","form_type":"4"}},{"id":3021081,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-09-29T16:40:53.000Z","date":"2020-09-29","kind":"exercise","acquired":true,"shares":586099,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of each of the Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares are held of record by Boxer Capital, LLC (\"Boxer Capital\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) MVA Investors, LLC (\"MVA Investors\") (iv) Aaron I. Davis, and (v) Joe Lewis (collectively, the \"Boxer Group\"). Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it does not have a pecuniary interest therein."}],"balance_after":1536099,"source":{"system":"sec-edgar","filing":"0001209191-20-052341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000120919120052341/doc4.xml","form_type":"4"}},{"id":3021080,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-09-29T16:40:53.000Z","date":"2020-09-25","kind":"purchase","acquired":true,"shares":950000,"price":18,"value":17100000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares are held of record by Boxer Capital, LLC (\"Boxer Capital\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) MVA Investors, LLC (\"MVA Investors\") (iv) Aaron I. Davis, and (v) Joe Lewis (collectively, the \"Boxer Group\"). Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it does not have a pecuniary interest therein."}],"balance_after":950000,"source":{"system":"sec-edgar","filing":"0001209191-20-052341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000120919120052341/doc4.xml","form_type":"4"}},{"id":3074343,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2020-07-29T21:38:37.000Z","date":"2020-07-28","kind":"exercise","acquired":false,"shares":158687,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares of Series B-2 Convertible Preferred stock held by Boxer Capital, LLC (\"Boxer Capital\") will convert automatically into 2,943,568 shares of Common Stock upon the closing of the Issuer's initial public offering. The shares of Series B-2 Convertible Preferred stock held by MVA Investors, LLC (\"MVA Investors\") will convert automatically into 48,691 shares of Common Stock upon the closing of the Issuer's initial public offering.  These amounts reflect a 1-for-3.3115 reverse stock split which became effective on July 20, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of Series B-2 Convertible Preferred stock is convertible at any time, at the Reporting Person's election, into Common Stock, based on the then-applicable conversion rate and has no expiration date."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares of Series B-2 Convertible Preferred stock held by Boxer Capital, LLC (\"Boxer Capital\") will convert automatically into 2,943,568 shares of Common Stock upon the closing of the Issuer's initial public offering. The shares of Series B-2 Convertible Preferred stock held by MVA Investors, LLC (\"MVA Investors\") will convert automatically into 48,691 shares of Common Stock upon the closing of the Issuer's initial public offering.  These amounts reflect a 1-for-3.3115 reverse stock split which became effective on July 20, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of Series B-2 Convertible Preferred stock held by Boxer Capital, LLC (\"Boxer Capital\") will convert automatically into 2,943,568 shares of Common Stock upon the closing of the Issuer's initial public offering. The shares of Series B-2 Convertible Preferred stock held by MVA Investors, LLC (\"MVA Investors\") will convert automatically into 48,691 shares of Common Stock upon the closing of the Issuer's initial public offering.  These amounts reflect a 1-for-3.3115 reverse stock split which became effective on July 20, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Series B-2 Convertible Preferred stock held by Boxer Capital, LLC (\"Boxer Capital\") will convert automatically into 2,943,568 shares of Common Stock upon the closing of the Issuer's initial public offering. The shares of Series B-2 Convertible Preferred stock held by MVA Investors, LLC (\"MVA Investors\") will convert automatically into 48,691 shares of Common Stock upon the closing of the Issuer's initial public offering.  These amounts reflect a 1-for-3.3115 reverse stock split which became effective on July 20, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of Series B-2 Convertible Preferred stock held by Boxer Capital, LLC (\"Boxer Capital\") will convert automatically into 2,943,568 shares of Common Stock upon the closing of the Issuer's initial public offering. The shares of Series B-2 Convertible Preferred stock held by MVA Investors, LLC (\"MVA Investors\") will convert automatically into 48,691 shares of Common Stock upon the closing of the Issuer's initial public offering.  These amounts reflect a 1-for-3.3115 reverse stock split which became effective on July 20, 2020."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Each share of Series B-2 Convertible Preferred stock is convertible at any time, at the Reporting Person's election, into Common Stock, based on the then-applicable conversion rate and has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The shares of Series B-2 Convertible Preferred stock held by Boxer Capital, LLC (\"Boxer Capital\") will convert automatically into 2,943,568 shares of Common Stock upon the closing of the Issuer's initial public offering. The shares of Series B-2 Convertible Preferred stock held by MVA Investors, LLC (\"MVA Investors\") will convert automatically into 48,691 shares of Common Stock upon the closing of the Issuer's initial public offering.  These amounts reflect a 1-for-3.3115 reverse stock split which became effective on July 20, 2020."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These securities are owned directly by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":48691},"source":{"system":"sec-edgar","filing":"0000899243-20-020687","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320020687/doc4.xml","form_type":"4"}},{"id":3074342,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2020-07-29T21:38:37.000Z","date":"2020-07-28","kind":"exercise","acquired":false,"shares":9593086,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares of Series B-2 Convertible Preferred stock held by Boxer Capital, LLC (\"Boxer Capital\") will convert automatically into 2,943,568 shares of Common Stock upon the closing of the Issuer's initial public offering. The shares of Series B-2 Convertible Preferred stock held by MVA Investors, LLC (\"MVA Investors\") will convert automatically into 48,691 shares of Common Stock upon the closing of the Issuer's initial public offering.  These amounts reflect a 1-for-3.3115 reverse stock split which became effective on July 20, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of Series B-2 Convertible Preferred stock is convertible at any time, at the Reporting Person's election, into Common Stock, based on the then-applicable conversion rate and has no expiration date."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares of Series B-2 Convertible Preferred stock held by Boxer Capital, LLC (\"Boxer Capital\") will convert automatically into 2,943,568 shares of Common Stock upon the closing of the Issuer's initial public offering. The shares of Series B-2 Convertible Preferred stock held by MVA Investors, LLC (\"MVA Investors\") will convert automatically into 48,691 shares of Common Stock upon the closing of the Issuer's initial public offering.  These amounts reflect a 1-for-3.3115 reverse stock split which became effective on July 20, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of Series B-2 Convertible Preferred stock held by Boxer Capital, LLC (\"Boxer Capital\") will convert automatically into 2,943,568 shares of Common Stock upon the closing of the Issuer's initial public offering. The shares of Series B-2 Convertible Preferred stock held by MVA Investors, LLC (\"MVA Investors\") will convert automatically into 48,691 shares of Common Stock upon the closing of the Issuer's initial public offering.  These amounts reflect a 1-for-3.3115 reverse stock split which became effective on July 20, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Series B-2 Convertible Preferred stock held by Boxer Capital, LLC (\"Boxer Capital\") will convert automatically into 2,943,568 shares of Common Stock upon the closing of the Issuer's initial public offering. The shares of Series B-2 Convertible Preferred stock held by MVA Investors, LLC (\"MVA Investors\") will convert automatically into 48,691 shares of Common Stock upon the closing of the Issuer's initial public offering.  These amounts reflect a 1-for-3.3115 reverse stock split which became effective on July 20, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of Series B-2 Convertible Preferred stock held by Boxer Capital, LLC (\"Boxer Capital\") will convert automatically into 2,943,568 shares of Common Stock upon the closing of the Issuer's initial public offering. The shares of Series B-2 Convertible Preferred stock held by MVA Investors, LLC (\"MVA Investors\") will convert automatically into 48,691 shares of Common Stock upon the closing of the Issuer's initial public offering.  These amounts reflect a 1-for-3.3115 reverse stock split which became effective on July 20, 2020."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Each share of Series B-2 Convertible Preferred stock is convertible at any time, at the Reporting Person's election, into Common Stock, based on the then-applicable conversion rate and has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The shares of Series B-2 Convertible Preferred stock held by Boxer Capital, LLC (\"Boxer Capital\") will convert automatically into 2,943,568 shares of Common Stock upon the closing of the Issuer's initial public offering. The shares of Series B-2 Convertible Preferred stock held by MVA Investors, LLC (\"MVA Investors\") will convert automatically into 48,691 shares of Common Stock upon the closing of the Issuer's initial public offering.  These amounts reflect a 1-for-3.3115 reverse stock split which became effective on July 20, 2020."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by Boxer Capital, which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) MVA Investors, (iv) Aaron I. Davis, and (v) Joe Lewis (collectively, the \"Boxer Group\"). Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it does not have a pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2943568},"source":{"system":"sec-edgar","filing":"0000899243-20-020687","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320020687/doc4.xml","form_type":"4"}},{"id":3074341,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T21:38:37.000Z","date":"2020-07-28","kind":"purchase","acquired":true,"shares":23552,"price":19,"value":447488.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"On July 28, 2020, MVA Investors purchased 23,552 shares of Common Stock of the Issuer at a price of $19.00 per share pursuant to an underwritten public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"On July 28, 2020, MVA Investors purchased 23,552 shares of Common Stock of the Issuer at a price of $19.00 per share pursuant to an underwritten public offering."}],"balance_after":72243,"source":{"system":"sec-edgar","filing":"0000899243-20-020687","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320020687/doc4.xml","form_type":"4"}},{"id":3074340,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T21:38:37.000Z","date":"2020-07-28","kind":"purchase","acquired":true,"shares":1401448,"price":19,"value":26627512.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"On July 28, 2020, Boxer Capital purchased 1,401,448 shares of Common Stock of the Issuer at a price of $19.00 per share pursuant to an underwritten public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"On July 28, 2020, Boxer Capital purchased 1,401,448 shares of Common Stock of the Issuer at a price of $19.00 per share pursuant to an underwritten public offering."}],"balance_after":4345016,"source":{"system":"sec-edgar","filing":"0000899243-20-020687","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320020687/doc4.xml","form_type":"4"}},{"id":3074339,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T21:38:37.000Z","date":"2020-07-28","kind":"exercise","acquired":true,"shares":48691,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of Series B-2 Convertible Preferred stock is convertible at any time, at the Reporting Person's election, into Common Stock, based on the then-applicable conversion rate and has no expiration date."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares of Series B-2 Convertible Preferred stock held by Boxer Capital, LLC (\"Boxer Capital\") will convert automatically into 2,943,568 shares of Common Stock upon the closing of the Issuer's initial public offering. The shares of Series B-2 Convertible Preferred stock held by MVA Investors, LLC (\"MVA Investors\") will convert automatically into 48,691 shares of Common Stock upon the closing of the Issuer's initial public offering.  These amounts reflect a 1-for-3.3115 reverse stock split which became effective on July 20, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of Series B-2 Convertible Preferred stock held by Boxer Capital, LLC (\"Boxer Capital\") will convert automatically into 2,943,568 shares of Common Stock upon the closing of the Issuer's initial public offering. The shares of Series B-2 Convertible Preferred stock held by MVA Investors, LLC (\"MVA Investors\") will convert automatically into 48,691 shares of Common Stock upon the closing of the Issuer's initial public offering.  These amounts reflect a 1-for-3.3115 reverse stock split which became effective on July 20, 2020."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These securities are owned directly by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":48691,"source":{"system":"sec-edgar","filing":"0000899243-20-020687","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320020687/doc4.xml","form_type":"4"}},{"id":3074338,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T21:38:37.000Z","date":"2020-07-28","kind":"exercise","acquired":true,"shares":2943568,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of Series B-2 Convertible Preferred stock is convertible at any time, at the Reporting Person's election, into Common Stock, based on the then-applicable conversion rate and has no expiration date."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares of Series B-2 Convertible Preferred stock held by Boxer Capital, LLC (\"Boxer Capital\") will convert automatically into 2,943,568 shares of Common Stock upon the closing of the Issuer's initial public offering. The shares of Series B-2 Convertible Preferred stock held by MVA Investors, LLC (\"MVA Investors\") will convert automatically into 48,691 shares of Common Stock upon the closing of the Issuer's initial public offering.  These amounts reflect a 1-for-3.3115 reverse stock split which became effective on July 20, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of Series B-2 Convertible Preferred stock held by Boxer Capital, LLC (\"Boxer Capital\") will convert automatically into 2,943,568 shares of Common Stock upon the closing of the Issuer's initial public offering. The shares of Series B-2 Convertible Preferred stock held by MVA Investors, LLC (\"MVA Investors\") will convert automatically into 48,691 shares of Common Stock upon the closing of the Issuer's initial public offering.  These amounts reflect a 1-for-3.3115 reverse stock split which became effective on July 20, 2020."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by Boxer Capital, which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) MVA Investors, (iv) Aaron I. Davis, and (v) Joe Lewis (collectively, the \"Boxer Group\"). Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it does not have a pecuniary interest therein."}],"balance_after":2943568,"source":{"system":"sec-edgar","filing":"0000899243-20-020687","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320020687/doc4.xml","form_type":"4"}},{"id":3079152,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":3,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":4,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":6,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-07-21T19:49:15.000Z","date":"2020-07-21","kind":"exercise","acquired":false,"shares":120460,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned directly and solely by MVA Investors, which has sole voting and dispositive power with respect to these securities. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":23622},"source":{"system":"sec-edgar","filing":"0000899243-20-019894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320019894/doc4.xml","form_type":"4"}},{"id":3079151,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":3,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":4,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":6,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-07-21T19:49:15.000Z","date":"2020-07-21","kind":"exercise","acquired":false,"shares":7064136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Braslyn Ltd. (\"Braslyn\"), (iv) Joseph C. Lewis, (v) MVA Investors, LLC (\"MVA Investors\") and (vi) Aaron I. Davis (collectively, the \"Boxer Group\"), and indirectly by Boxer Management and Joseph C. Lewis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1385291},"source":{"system":"sec-edgar","filing":"0000899243-20-019894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320019894/doc4.xml","form_type":"4"}},{"id":3079150,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":3,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":4,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":6,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T19:49:15.000Z","date":"2020-07-21","kind":"purchase","acquired":true,"shares":722222,"price":18,"value":12999996.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Braslyn Ltd. (\"Braslyn\"), (iv) Joseph C. Lewis, (v) MVA Investors, LLC (\"MVA Investors\") and (vi) Aaron I. Davis (collectively, the \"Boxer Group\"), and indirectly by Boxer Management and Joseph C. Lewis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":2107513,"source":{"system":"sec-edgar","filing":"0000899243-20-019894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320019894/doc4.xml","form_type":"4"}}],"next_cursor":"2020-07-21T19:49:15.000000Z,3079150"}